Demo: How an expert article connects to sources, FAQs and criteria
Direct answer
This page is a labelled template demonstration. It shows the article structure and the linkage to sources, FAQs, criteria, products and comparison pages — it contains no new product or health statements.
One consistent layout for every article, with a free content order per topic: modules are added, reordered or removed.
On this page
What this demonstration shows
This page is a labelled demonstration of the article template. It introduces no new product statements. It shows how an article connects its statements to approved sources, FAQs, criteria, product data and comparison pages — and how missing information stays visible.
Key takeaways
- The record sits next to the statement — not in a footnote at the end.
- Every source names its type, date and limitations.
- Missing information stays visible as missing.
- The article is linked to criteria, product data and FAQs instead of duplicating them.
Demonstration copy — not a product statement.
What the record behind this statement shows
The statement below rests on the end-product analyses listed here. Source, status, date and limitations stay visible — including where a value is missing.
- MVS product evidenceCOA · 2026-09-15
Finished-product analysis batch MVS-2609
The source establishes the described relationship to the stated extent.
Limitations: Relates to the documented batch or the described scope of investigation.
- MVS product evidenceLaborbericht · 2026-09-15
Laboratory report oxidation (TOTOX, PV, AV)
The source establishes the described relationship to the stated extent.
Limitations: Relates to the documented batch or the described scope of investigation.
How the linkage works
The article stores no copy of the values. It references the records: product data, criteria, FAQs and sources stay maintained in one place. If an approved value changes there, the article is flagged for editorial review.
Frequently asked questions on this topic
The answers come from the central FAQ system, where they are maintained.
All answers come from the centrally maintained FAQ system.
Sources and reference basis
- 1
Finished-product analysis batch MVS-2609
MVS Pharma · COA · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 2
Recommendations on omega-3 intake
MVS Pharma · Fachgesellschaft · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 3
Heavy metals analysis, finished product
MVS Pharma · Laborbericht · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 4
Capsule and material testing
MVS Pharma · Laborbericht · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 5
Laboratory report oxidation (TOTOX, PV, AV)
MVS Pharma · Laborbericht · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 6
Review: contaminants in fish oil
MVS Pharma · Systematischer Review · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 7
EFSA: scientific assessment on omega-3
MVS Pharma · Regulatorisches Dokument · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 8
Manufacturer disclosures Zinzino BalanceOil+
MVS Pharma · Öffentliche Produktseite · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 9
Retail data Doppelherz Omega-3
MVS Pharma · Handelsseite · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 10
Dioxins and PCB analysis
MVS Pharma · Laborbericht · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 11
GOED: monograph on oxidation values
MVS Pharma · Wissenschaftliche Publikation · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 12
Review: bioavailability of rTG and EE
MVS Pharma · Systematischer Review · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 13
Study: oxidation during storage
MVS Pharma · Wissenschaftliche Publikation · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
- 14
Manufacturer disclosures NORSAN Omega-3 Pure
MVS Pharma · Öffentliche Produktseite · 2026-09-15
Note: Relates to the documented batch or the described scope of investigation.
Transparency & corrections
This article names its source, status and review date. If you find an error you can submit a correction — it is reviewed, never applied automatically.
- Author
- MVS Redaktion
- Scientific review
- Fachliche Prüfung MVS
- Published
- 2026-10-12
- Last reviewed
- 2026-10-12